Search Press releases

25 Jun 2021

Disposals of own shares

Read More
25 Jun 2021

UCB Receives Positive CHMP Opinion Recommending Approval of BIMZELX[®*] (bimekizumab) in the EU for the Treatment of Adults with Moderate to Severe Plaque Psoriasis

Read More
18 Jun 2021

Disposals of own shares

Read More
11 Jun 2021

Disposals of own shares

Read More
4 Jun 2021

Disposals of own shares

Read More
1 Jun 2021

EULAR 2021: New Data from UCB’s Rheumatology Portfolio Demonstrates Real World Value for Patients with axSpA, PsA, and Women of Childbearing Age

Read More

Stay up-to-date on the latest news and information from UCB